scholarly journals Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

2018 ◽  
Vol Volume 5 ◽  
pp. 1-7 ◽  
Author(s):  
Bin Liang ◽  
Siyang Yao ◽  
Jiapeng Zhou ◽  
Zongkui Li ◽  
Tianqi Liu
2020 ◽  
Vol 28 ◽  
pp. 204020662092133 ◽  
Author(s):  
Mohamed A Abd El Aziz ◽  
Rodolfo Sacco ◽  
Antonio Facciorusso

Hepatitis B virus is mainly considered to cause hepatocellular carcinoma which is the fourth leading cause of cancer-related mortality worldwide. Treatment of Hepatitis B virus with nucleos(t)ide analogues can decrease the progression of the disease and subsequently decreases the incidence of hepatocellular carcinoma. In this review, we have discussed the different classes of nucleos(t)ide analogues used in the treatment of Hepatitis B virus and their relationship with the development of hepatocellular carcinoma. Furthermore, we discussed the effect of treatment of Hepatitis B virus with Nucleoside analogues (NAs) before, during and after surgery, chemoembolization, radiofrequency ablation, and chemotherapy for the treatment of hepatocellular carcinoma.


Sign in / Sign up

Export Citation Format

Share Document